The West Virginia Medical Cannabis Advisory Board declined to enact a proposed cap on THC on medical cannabis products, saying they need more information before making a decision, WV Public Broadcasting (WVPB) reports. The rule was proposed by the board’s Health and Medical Workgroup and would have capped THC in medical cannabis products in the state at 10%.
Dr. James Berry, a psychiatrist and the leader of the workgroup, claimed that medical evidence supports the cap, saying the evidence supports “the possibility of using THC potencies of 10 percent or less to help with any medical condition.”
“And at the same time, there has been a preponderance of evidence associating higher THC content with a number of public health concerns, such as suicide, psychosis, in addition, depression, anxiety, these sorts of things.” — Berry, via WVPB
Dr. Cody Peterson, a pediatric pharmacist who practices in California, didn’t appear to support the cap, although he said he does “see problems with cannabis” in his role as a medical practitioner.
“The most problematic products I see are from the black market and setting THC limits, especially those THC limits well below the products that are currently available on the market and people are accustomed to will create more demand, more incentive, and more profitability in the illicit market,” he said, “and you create more issues than you’re intending to correct.”
The West Virginia Medical Cannabis Advisory Board will meet again on January 5 and could reconsider the cap at that meeting.
Get daily cannabis business news updates. Subscribe
